ABCC1 and Miyoshi myopathy: Accordingly, addition of the ABCC1 inhibitor MK-571 to untreated and Dox-treated SKO-007(J3) resulted in accumulation of intracellular cGAMP in a dose dependent fashion, suggesting that ABCC1 is responsible, to some extent, for cGAMP export in MM cells (Figure 1D).